Belmont, MA, United States of America

Susovan Mohapatra

This inventor holds 3 USPTO granted patents and 6 published patent applications. Top assignee: Wave Life Sciences Ltd.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susovan Mohapatra. Retrieved from https://idiyas.com/inventor/susovan-mohapatra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Susovan Mohapatra: Oligonucleotide Innovation at Wave Life Sciences

Introduction

Susovan Mohapatra is an inventor based in Belmont, Massachusetts, whose patent work includes oligonucleotide compositions and methods of use. He works at Wave Life Sciences Ltd., a biotechnology company focused on genetic medicines.

Latest Patents

Mohapatra’s latest listed patent is “Oligonucleotide Compositions and Methods of Use Thereof.” The disclosure describes chirally controlled oligonucleotides and compositions, along with methods for making and using them. Some embodiments are designed to produce cleavage patterns that differ from those of reference compositions, including single-site cleavage within a complementary sequence of a nucleic acid polymer. The disclosed designs may vary in base sequence, base and sugar modifications, backbone modifications, stereochemistry, or combinations of these features.

Mohapatra is associated with 3 patents.

Career Highlights

At Wave Life Sciences Ltd., Mohapatra’s patent work addresses the design and use of oligonucleotide compositions. The disclosed approaches explore how molecular structure and stereochemical control can influence nucleic-acid cleavage.

Collaborations

Mohapatra’s listed coworkers include Chandra Vargeese and Nenad Svrzikapa. Their shared association with Wave Life Sciences reflects a collaborative research environment focused on genetic medicines and oligonucleotide technologies.

Conclusion

Susovan Mohapatra’s patent portfolio highlights his contributions to oligonucleotide innovation, particularly chirally controlled compositions and methods for influencing nucleic-acid cleavage.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…